Maria Nirvana Formiga, MD, PhD

Medical Oncologist @A.C.Camargo Cancer Center #oncogenetics #GUoncology #sarcoma

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

In >230,000 individuals from the Helix Research Network, Lynch syndrome cancer risk varied substantially by gene @JCOOA_ASCO @kellyschiabor
MLH1/MSH2 showed the highest colorectal cancer risk, while PMS2 demonstrated markedly lower penetrance & later onset
https://t.co/AGPsIvQehH

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

For the 1st time in history, there are more people >65 than <5 globally
Cancer care is aging and we’re not ready
As @WilliamDale_MD highlighted: geriatric + palliative care must become core, not optional @PallOncCoP
@realbowtiedoc @RyanNipp @IshwariaMD @DarcyBurbage @JamesFanWu

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

Two immersive days in #kidneycancer
At @GustaveRoussy with amazing Medical Oncology Team
@AlbigesL @SoaresAndrey et al
#accamargocancercenter

[Enrique Grande @drenriquegrande]

Todo lo que sabemos hoy sobre el cáncer de mama: diagnóstico, tratamientos y factores de riesgo https://t.co/09A8HqPg1T via @uestudio_es @quironsalud @telva @elmundoes

[Neeraj Agarwal, MD, FASCO @neerajaiims]

Just started👉2025 United States #ProstateCancer Consensus Conference (USPCCC) 👉with @AlanBryce9 ‘s introductory remarks. @philkuo @cityofhope debating for PSMA PET for treatment selection. Caveat👉 Medical conditions with false positive PSMA PET lesions 👇@urotoday @PCFnews

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

@walmarthelp Need a answer for my request.
#consumerRights

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

Terrific work in #metastaticrcc
Congrats @mzugman and his big mentor @montypal
Dr. Tannir Award @ConquerCancerFd
@MDAndersonNews @cityofhope

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

Brilliant talk about #molecularsubtypes #renalcellcarcinoma by @montypal @ASCO #ASCO25

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

@crisbergerot @PauloBergerot @ASCO @montypal @sarah_c_hopkins @AmandaBinDC @NarjustFlorezMD Congrats!!!!

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival https://t.co/790ByVThsC
influence of drug access on #overalsurvival #prostatecancer
@lucianaholtz
@StenioZequi

[Rachel Riechelmann @RachelRiechelm2]

@GRossato_Onc

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

Excellent overview 1st line therapy in #renalcellcarconoma . Always brilliant talk by @montypal
@AlbigesL At #ESMO2024

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

#ESMO24 @luciana45069110 @AldoLADETTINO @acccancercenter

[Aldo L. A. DETTINO @AldoLADETTINO]

Onco-urologia do ⁦⁦@acccancercenter⁩ ⁦@myESMO⁩ #Esmo 2024 . ⁦@nirvanaformiga⁩

[Milena shizue Tariki @TarikiMilena]

Wonderful time with colleges from México and Brazil diving in thee prostate cancer Journey
@acccancercenter @StenioZequi José Augusto Rinck @thiagocmourao Daniel Garcia @nirvanaformiga @AldoLADETTINO @luciana45069110 @ederbrazaojr Rafael Zanotti

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

#prostatecancer @OncologyBio
Excelente evento de discussão de câncer de próstata! @SoaresAndrey

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

#SarcomaAwareness
@acccancercenter
@_CamposFernando
#beatcancer

[Sumanta K. Pal, MD, FASCO @montypal]

Huge congrats to #NizarTannirMD @MDAndersonNews who drove forward this impt trial (#PIVOT09) comparing pegylated #IL2/#nivolumab to #TKI; was a privelege to work w him & others (@nirvanaformiga @neerajaiims @Daniel_J_George) on this trial now in @JCO_ASCO. PFS & OS no different; RR a bit lower in experimental arm. We saw @brian_rini & @DrChoueiri present genomic data from #KN426 & #CLEAR at #ASCO24 & prev saw genomic data from #CM214 presented by @motzermd. Wish we had the opportunity to look at that here - given modest activity w #bempeg, could offer insights on which pts could get IO monotx - something we discuss often after #KN427 but do infrequently in practice.

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

A Phase III Randomized Study (PIVOT-09) | Journal of Clinical Oncology https://t.co/2L50KSZx41
Honored to have participated in this #RCC trial @acccancercenter
With big #GU oncologists
Dr. Tannir @MDAndersonNews
@montypal @neerajaiims @Daniel_J_George and others

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

@neerajaiims @BioMedCentral @theNCI @AdrianaMColetta @NeliMUlrich @OncoAlert @PCF_Science @huntsmancancer @urotoday @montypal @umangtalking @maughanonc @soulehoward1 @DrChoueiri @shilpaonc @VivekSubbiah @AzadOncology @Huntsman_GU @EAntonarakis Excellent study @neerajaiims and all team! Congrats!
look it that! @AldoLADETTINO @StenioZequi

[Maria Nirvana Formiga, MD, PhD @nirvanaformiga]

Good to discuss with our GU team @StenioZequi @AldoLADETTINO

[Aldo L. A. DETTINO @AldoLADETTINO]

@acccancercenter #Rim #Cancer #cirurgia